
Validea's guru fundamental report assigns UnitedHealth Group (UNH) a 77% rating based on the Martin Zweig Growth Investor model, positioning it as a large-cap growth stock in the insurance sector. Although UNH passes several key metrics, including P/E ratio, sales growth, and current quarter earnings, its overall score falls short of the 80% threshold for 'some interest' within the Zweig strategy, notably failing criteria related to consistent revenue growth relative to EPS and sustained earnings growth over multiple quarters.
UnitedHealth Group (UNH) presents a mixed but predominantly positive profile according to Validea's quantitative analysis based on the Martin Zweig growth model, achieving a score of 77%. While this score is solid, it falls just below the 80% threshold that indicates 'some interest' from the strategy. The model identifies UNH as a large-cap growth stock that successfully passes several key fundamental tests, including a reasonable P/E ratio, strong sales growth rate, positive current quarter earnings, earnings persistence, and favorable insider transaction signals. However, the analysis also flags critical areas of weakness that prevent a stronger rating. Specifically, UNH fails on criteria related to earnings momentum and quality; the model indicates that revenue growth is not keeping pace with EPS growth, and the earnings growth rate over the past several quarters has been inconsistent. Furthermore, its current quarterly EPS growth, while accelerating from the prior three quarters, does not exceed its longer-term historical growth rate, suggesting a lack of sustained earnings acceleration, which is a core tenet of the Zweig methodology.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment